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Seasonal hyperacute panuveitis (SHAPU) is a potentially blinding ocular disease occurring in Nepal that
principally affects young children. Random amplification of partially purified vitreous fluid (VF)–derived
nucleic acid revealed the presence of human anelloviruses in VF of SHAPU patients. In a comparative study
of patients with different ocular pathologies, SHAPU patients were at highest risk of harboring anelloviruses
in their eyes. The majority of SHAPU patients had multiple anelloviruses in their VF. The ocular anellovirus
load in SHAPU and non-SHAPU patients did not differ and no SHAPU-specific anellovirus variant was
detected. Analysis of paired serum and VF samples from SHAPU and non-SHAPU patients showed that the
anellovirus detected in VF samples most likely originated from the systemic viral pool during viremia, poten-
tially through breakdown of the blood-ocular barrier. The detection of anelloviruses in VF samples of uveitis
patients, profoundly so in SHAPU patients, is imperative and warrants elucidation of its clinical significance.
Seasonal hyperacute panuveitis (SHAPU) is a sight-
threatening ocular disease characterized as an acute
diffuse fulminant ocular inflammation [1–5]. The
disease was first diagnosed in Nepal about 35 years ago
and has only been reported in Nepal. SHAPU prefer-
entially affects young children [2, 5], who present with
sudden onset of unilateral ocular redness, loss of
vision, and leukocoria due to massive exudation in the
vitreous cavity [2]. A hypopyon and dense fibrinoid
reaction in the anterior chamber are commonly ob-
served [2]. Early therapeutic vitrectomy of SHAPU
patients may preserve some vision and anatomical
integrity of the globe. Most affected eyes, however, lose
all functional vision. SHAPU is commonly reported
during the autumn months, with no sex predilection [2,
4]. The etiological cause of SHAPU is unknown.
However, SHAPU patients in Nepal relate a recent his-
tory of close contact with white moths, whose appear-
ance in a 2-year cycle coincides with the onset of new
SHAPU cases [2, 4]. A pathogenic role of white moths
in SHAPU has been postulated, but never proven [2].
Uveitis is a heterogeneous group of ocular diseases
characterized by inflammation of the uvea either caused
by potential autoimmune responses (endogenous uveitis)
or initiated by an intraocular infection (exogenous
uveitis). The pathology of exogenous uveitis (eg, bacterial
endophthalmitis and herpetic uveitis) involves both the
cytopathic effect of the infectious agent and a local patho-
genic immune response. Endophthalmitis is an acute
panuveitis that commonly occurs after intraocular sur-
gery,particularlycataractsurgery[6].Patientspresentwith
severe pain and redness of the conjunctiva and episclera
and a hypopyon is often observed. Various communal
bacteria and fungi are identified as initiating pathogens
[6]. Because of similarities in clinical symptoms and in-
cidental detection of bacteria in ocular fluids, SHAPU
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has also been referred to as seasonal endophthalmitis [2]. How-
ever, whereas neutrophils predominate in the pathogenesis of
endophthalmitis, the ocular infiltrating cells in SHAPU resemble
those of viral uveitis, mainly consisting of activated lymphocytes
andmacrophages [5,7,8].Varicella-zoster virus has been detected
in aqueous humor of a patient with presumed SHAPU [9].
Infectious diseases, both emerging and reemerging, pose a
continuous health threat and disease burden on humanity. Many
(re)emerging viruses have been identified in recent years, includ-
ing human immunodeficiency virus, hepatitis C virus, H5N1
avian influenza A virus, and severe acute respiratory syndrome
coronavirus [10]. New technologies have been developed to
increase virus identification, such as virus microarrays, sequence-
independent amplification, and sequencing of viral nucleic acids,
which has already resulted in identification of novel viruses [11].
Yet, our knowledge of viruses that infect humans is still incom-
plete, and many acute and chronic diseases with unknown etiol-
ogy may be caused by as yet unidentified viruses.
The aim of the current study was to determine the potential
role of a viral infection in SHAPU. Vitreous fluid (VF) samples
of SHAPU patients and disease controls were subjected to
detailed polymerase chain reaction (PCR) and sequence anal-
yses to detect the presence of viruses in diseased eyes.
MATERIALS AND METHODS
Clinical Specimens
VF samples were obtained from patients with SHAPU
(n = 32) and patients suffering from retinal detachment
(n = 18). VF samples of patients with endophthalmitis (n = 21)
and nonbacterial/fungal infectious uveitis (eg, herpesvirus- or
Toxoplasma gondii–induced posterior uveitis; n = 29) were in-
cluded as non-SHAPU infectious controls. All VF samples
were surplus specimens collected during diagnostic or thera-
peutic vitrectomy. The SHAPU VF samples were obtained
from patients treated at the Tilganga Institute of Ophthal-
mology (Kathmandu, Nepal). The remaining VF samples
were obtained from patients enrolled at the Rotterdam Eye
Hospital (the Netherlands) and the F. I. Proctor Foundation
(San Francisco, California). To ensure anonymity, clinical
samples were assigned a sample number with no clinical iden-
tifiers attached. Additionally, paired serum and VF samples
were collected prospectively, with written informed consent
obtained from the patients and/or parents at the Tilganga In-
stitute of Ophthalmology from 8 additional SHAPU patients
and 8 non-SHAPU posterior uveitis patients (Table 1). All
study procedures were performed in compliance with relevant
laws and institutional guidelines and in accordance with the
ethical standards of the Declaration of Helsinki.
Sequence-Independent RNA and DNA Virus Screening of VF
Samples
Nineteen VF samples, obtained from endophthalmitis (n = 9)
and SHAPU (n = 10) patients, were available for virus dis-
covery studies using random PCR amplification of nucleic
acids [12–15]. Large-scale molecular RNA and DNA virus
screening, based on host nucleic acid depletion, sequence-
independent amplification, and sequencing of partially purified
Table 1. Patient Characteristics and Anellovirus Prevalence in Paired Serum and Vitreous Fluid Samples of Nepalese Uveitis Patients
Patient ID Age (y), Sex Clinical Diagnosis TTVa TTMDVa TTMVa
SV-1 2.5, Female SHAPU Pos/Pos Neg/Neg Pos/Pos
SV-2 10, Male SHAPU Pos/Pos Pos/Neg Pos/Pos
SV-3 2, Male SHAPU Pos/Pos Pos/Pos Pos/Pos
SV-4 1.5, Male SHAPU Pos/Pos Pos/Pos Pos/Pos
SV-5 7, Female SHAPU Pos/Pos Neg/Pos Neg/Neg
SV-6 3, Female SHAPU Pos/Pos Pos/Pos Pos/Pos
SV-7 10, Male SHAPU Pos/Pos Pos/Pos Pos/Pos
SV-8 2, Male SHAPU Pos/Pos Pos/Pos Pos/Pos
NV-1 35, Female Endophthalmitis Pos/Pos Neg/Neg Neg/Pos
NV-2 45, Female Endophthalmitis Pos/Pos Neg/Neg Neg/Neg
NV-3 74, Female Endophthalmitis Pos/Pos Neg/Pos Neg/Pos
NV-4 38, Male Endophthalmitis Neg/Pos Neg/Neg Neg/Pos
NV-5 50, Female Endophthalmitis Neg/Pos Neg/Neg Neg/Pos
NV-6 45, Female Idiopathic panuveitis Neg/Pos Neg/Pos Neg/Neg
NV-7 29, Female Sarcoid uveitis Neg/Pos Neg/Pos Neg/Pos
NV-8 39, Female Herpetic retinitis Neg/Pos Neg/Neg Neg/Pos
Abbreviations: SHAPU, seasonal hyperacute panuveitis; TTV, torque teno virus; TTMDV, torque teno midi virus; TTMV, torque teno mini virus.
aPolymerase chain reaction result for the indicated anelloviruses in paired vitreous fluid (before forward slash) and serum (after forward slash) of the indicated
uveitis patient.
1878 • JID 2012:205 (15 June) • Smits et al
VF-derived RNA and DNA, was performed on VF samples
diluted 1:4 in phosphate-buffered saline, essentially as
described previously [12–15].
Human Torque Teno Virus–Specific PCR Analyses
Total nucleic acid was extracted from an aliquot (∼50 µL) of the
VF samples using the MagNA Pure LC total nucleic acid iso-
lation kit and the MagNA Pure LC isolation station (Roche),
according to the manufacturer’s instructions. A highly conserved
genomic area located just downstream of the TATA box, corre-
sponding to nucleotides (nt) 99–227 in the prototype torque
teno virus (TTV) isolate (TA278), nt 34–170 in the prototype
torque teno midi virus (TTMDV) isolate (MD1-073), and nt
178–303 in the prototype torque teno mini virus (TTMV) isolate
(CBD231), was amplified using a nested PCR, as described pre-
viously [16]. Classification of the anellovirus amplicons into the
3 distinct genera human Alphatorquevirus, Betatorquevirus, and
Gammatorquevirus was based on assigning sizes to PCR frag-
ments separated by electrophoresis and detected using a 3130XL
genetic analyzer (Applied Biosystems) [17].
A human TTV–specific TaqMan assay was developed using
primers NG779, NG780, and NG785 [16] and probe VS594
(5′-CCGAGGGCGGGTGCCG-3′) labeled with 6-carboxy-
fluorescein and 6-carboxy-tetramethyl-rhodamine at the 5′ and
3′ ends, respectively. Reactions were carried out in a 25-µL
format with 1× TaqMan Universal PCR Master Mix (Roche);
0.25 µL primers NG779 (10 µM), NG780 (10 µM), and
NG785 (20 µM); 0.125 µL probe VS594 (20 µM); and 2.5 µL
isolated nucleic acid. The conditions used for amplification
were 50°C for 2 minutes, followed by 95°C for 10 minutes,
and 40 cycles of denaturation at 95°C for 15 seconds and
annealing/extension at 60°C for 60 seconds on an ABI PRISM
7000 (Applied Biosystems). A cloned TTV amplicon standard
was also taken to define the amount of TTV copies/mL VF.
DNA Sequencing and Sequence Analyses
Amplicons were purified using the MSB HTS PCRapace/C kit
(Invitek GmbH), according to the manufacturer’s instructions.
Sequencing was performed on purified amplicons using Big
Dye Terminator V3.1 cycle sequencing kit (Applied Biosys-
tems) and a 3130XL or 3700 genetic analyzer (Applied Biosys-
tems). All obtained sequences were screened for homology
with known sequences deposited in GenBank (http://www.
ncbi.nlm.nih.gov/genbank/) using the Basic Local Alignment
Search Tool (BLAST) by blastn and tblastx [18]. The analysis
of randomly amplified amplicons from VF focused on virus
discovery, that is, sequences were of interest when homology
to viruses that infect mammals was observed.
Phylogenetic Analysis
Multiple alignments were created using ClustalX (2.0.10) [19].
Phylogenetic analyses were carried out with Molecular
Evolutionary Genetics Analysis (MEGA), version 4.1 beta
[20], in a manner similar to that used in previous TTV studies
[21, 22]. Phylogenetic trees were calculated using neighbor-
joining with p distance, and bootstrap analysis was performed
with 1000 replicates.
Statistical Analyses
Data between different conditions were compared using the
Fisher exact test (for binomial data) and Mann–Whitney test
(for numeric data). Differences were considered significant at
P < .05.
RESULTS
Molecular Virus Screening of VF Samples of SHAPU and
Endophthalmitis Patients
Nineteen VF samples were obtained from patients with
endophthalmitis (n = 9) and SHAPU (n = 10) to determine the
potential presence of viral pathogens. The VF-derived RNA
and DNA were subjected to random PCR amplification and
subsequent sequencing of approximately 80 amplicons
(average length =∼350 bp) per VF-derived nucleic acid
sample. The analysis focused on identification of viruses infect-
ing mammals. Potential viral nucleic acid sequences were
detected in 1 endophthalmitis sample and 2 SHAPU VF samples.
An approximately 630-bp amplicon with high homology to
human herpesvirus 5 was identified in the endophthalmitis
sample. A 424-bp amplicon with homology to a TTMV was
identified in 1 of the SHAPU samples; in the second SHAPU
sample 17 amplicons (ranging in size from approximately 200 bp
to 550 bp) with homology to different parts of the TTMV and
TTMDV genomes were identified (data not shown).
TTVs (family Anelloviridae) are small nonenveloped
viruses with a circular, single-stranded DNA genome of nega-
tive polarity between 2.1 kb and 3.9 kb long. The family Anel-
loviridae contains 9 genera: Alpha-. Beta-, Gamma-, Delta-,
Epsilon-, Eta-, Iota-, Theta-, and Zetatorquevirus [23]. The
Alpha-, Beta-, and Gammatorquevirus genera contain anello-
viruses that infect humans. TTV infections are commonly ac-
quired during early childhood during which the virus
establishes a chronic productive infection with long-lasting de-
tectable viremia [23]. TTVs are endemic worldwide and can
be detected in blood and various tissues in the body, including
cerebrospinal and bronchioalveolar lavage fluid samples [23].
TTV (genus Alphatorquevirus) is classified into at least 29
genotypes with nucleotide divergence of >30%, consisting of 5
major genetic groups (groups 1–5) with a sequence divergence
of >50% [23–25]. For TTMV (genus Betatorquevirus), highly
divergent groups have been proposed [21, 26, 27], and for
TTMDV (genus Gammatorquevirus), approximately 33%
sequence diversity has been observed across full-length
genomes [28].
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Prevalence of TTV, TTMDV, and TTMV in VF Samples of
SHAPU Patients and Disease Controls
To corroborate the finding of TTVs in the VF of SHAPU
patients, a nested PCR specific for differential detection of 3
human anelloviruses from the genera Alpha-, Beta-, and Gam-
matorquevirus was performed on a set of VF samples obtained
from SHAPU patients (n = 32) and non-SHAPU infectious
disease control patients with endophthalmitis (n = 21) and in-
fectious uveitis (n = 29). VF obtained from patients with
retinal detachment (n = 18) was used as noninfectious control
samples (Figure 1).
All VF samples from retinal detachment patients were nega-
tive for TTV, TTMDV, and TTMV. Among infectious uveitis
patients, TTV and TTMV was detected in 5 of 29 (17%) and 3
of 29 (10%) VF samples, whereas TTMDV was not detected.
No correlation between the presence of the anelloviruses and
the initiating herpesvirus and parasite nor the clinical picture
was found (data not shown). Among endophthalmitis
patients, 10 of 21 (47%) were positive for TTV, 3 of 21 (14%)
were positive for TTMDV, and 6 of 21 (28%) were positive for
TTMV. The VF of 30 of 32 SHAPU patients contained either
1 or multiple anelloviruses. The viruses TTV, TTMDV, and
TTMV were detected in 29 of 32 (91%), 19 of 32 (59%), and
22 of 32 (69%) SHAPU VF samples. The prevalence of all 3
viruses in VF of SHAPU patients was significantly higher
compared with non-SHAPU patients (Figure 1). Notably, 18
of 32 (56%) VF samples of SHAPU patients were positive
for all 3 TTVs. Among the non-SHAPU patients, only 2
endophthalmitis cases also had all 3 anelloviruses in their VF
sample (data not shown).
Next, we performed real-time PCR analysis to compare the
intraocular loads of TTV in SHAPU (n = 21) and non-
SHAPU patient (n = 15) samples (Figure 2). The TTV loads
were not significantly different between both patient cohorts,
with a median viral load of 432 TTV genome equivalent
copies per milliliter VF. It should be noted that the TTV-
specific real-time PCR assay was less sensitive compared with
the nested PCR described above. As such, viral loads by real-
time PCR could only be determined in 65% (SHAPU cases)
and 45% (non-SHAPU cases) of the initially TTV-positive VF
samples (Figure 2 and data not shown).
Phylogenetic Analyses of Ocular-Derived TTV Sequences of
SHAPU Patients
To obtain more insight into the presence of the anelloviral
genomes in VF samples of SHAPU patients, the genotype of
ocular-derived TTV from SHAPU and non-SHAPU patients
was determined. Because SHAPU has only been described in
Nepal, we hypothesized the existence of a specific SHAPU-
inducing TTV variant. Genomes of TTV isolates share low
DNA sequence homology [16]. However, a short stretch
(∼130 bp) of the intergenic nontranslated region is identified
as being highly conserved among all human TTV isolates and
is used to both demonstrate TTV infections and to genotype
clinical isolates [16]. To test our hypothesis, we cloned and
sequenced VF-derived amplicons (∼8 clones per VF sample)
from this particular genomic region from 10 SHAPU patients.
Multiple different TTV variants (average 2.3 variants, range
1–5) were observed in 7 of 10 SHAPU samples. A neighbor-
joining phylogenetic tree was created using the ocular-derived
SHAPU TTV amplicons and corresponding sequences of
TTV, TTMDV, and TTMV strains previously deposited in the
GenBank database (Figure 3). The SHAPU-associated TTV
sequences showed 70%–100% similarity to each other, but
they did not belong to the same phylogenetic clade. Moreover,
SHAPU TTV sequences from the same sample often did not
group together, suggesting that patients are infected with mul-
tiple different TTV variants or even genotypes.
TTVAnalyses of Paired Serum and VF Samples of Nepalese
Patients With Those of SHAPU and Non-SHAPU Patients
The increased TTV prevalence in SHAPU patients may be
owing to differences in the geographic origin of the non-
SHAPU patients included as disease controls. Whereas the
Figure 1. Prevalence of anelloviruses in vitreous fluid (VF) of uveitis patients. The percentage of anellovirus-positive VF samples for torque teno virus
(left panel), torque teno midi virus (middle panel), and torque teno mini virus (right panel) for the indicated patients with ocular disease are shown.
Fisher exact test was used to compare differences between patient groups. Abbreviation: SHAPU, seasonal hyperacute panuveitis.
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SHAPU patients were recruited in Nepal, all non-SHAPU
patients were either Dutch or US citizens. To investigate this
potential confounding factor, paired serum and VF samples of
additional SHAPU patients (n = 8) and non-SHAPU patients
(n = 8, including 5 endophthalmitis patients) were prospec-
tively collected at the Tilganga Institute of Ophthalmology
(Table 1).
The paired serum and VF samples of the Nepalese SHAPU
and non-SHAPU patients were analyzed using the nested an-
ellovirus PCR. The prevalence of the 3 anelloviruses in VF
from both patient groups was similar to those observed in the
first patient cohort analyzed (Figure 1), confirming the high
prevalence of anelloviruses in SHAPU VF samples (Table 1).
In the serum samples, however, no significant difference in
the detection of TTV, TTMDV, and TTMV was observed
between the patient groups. The prevalence of anellovirus
viremia was very high in both patient groups (Table 1). All
patients had TTV, three-quarters had TTMV, and about half
had TTMDV viremia at time of sampling. In SHAPU patients,
the presence of anelloviruses in the paired VF and serum
samples correlated. Except for 1 SHAPU case (patient SV-2),
the anellovirus PCR disparate VF/serum pairs consisted
always of an anellovirus PCR-negative VF sample in a viremic
patient (Table 1).
Ocular inflammation is commonly associated with blood-
ocular barrier perturbation, specifically, increased barrier per-
meability [29]. The matching anellovirus PCR data of the
paired VF and serum samples suggest that the anelloviruses
detected in VF may have originated from circulating anello-
virus in viremic patients. To address this option, we genotyped
the VF- and serum-derived TTV pool of 8 SHAPU and 4
non-SHAPU patients. Multiple different TTV variants were
detected in the serum (average ∼2.6 variants, range 1–5) and
VF (average ∼3 variants, range 1–5) samples. The same TTV
variant was detected in serum and VF of 6 of 8 SHAPU
patients and 2 of 4 non-SHAPU patients (data not shown),
suggesting that the anellovirus detected in the VF samples
may have originated from the systemic TTV pool, potentially
through breakdown of the blood-retina barrier. Due to the
relatively low sensitivity of the TTV TaqMan assay, the TTV
load in only 2 paired VF and serum samples could be deter-
mined; this was too low to be analyzed statistically (data not
shown).
DISCUSSION
The aim of the current study was to determine whether
viruses might be causally involved in the potentially blinding
Figure 2. Torque teno virus (TTV) load in vitreous fluid (VF) of uveitis
patients. The TTV load in TTV polymerase chain reaction (PCR)–positive
VF samples of patients (numbers of patients assayed are shown in par-
entheses) with the indicated ocular diseases was determined by real-
time quantitative PCR (qPCR) and presented as TTV genome equivalent
copies per milliliter VF (geq/mL). The horizontal bars indicate the median
TTV load. The detection limit of the TTV-specific qPCR assay was 10
geq/mL. Abbreviation: SHAPU, seasonal hyperacute panuveitis.
Figure 3. Phylogenetic analysis of vitreous fluid (VF)–derived torque
teno virus (TTV) variants from patients with seasonal hyperacute panuvei-
tis (SHAPU). A phylogenetic tree of a fragment (71–76 bp) of the non-
translated region of TTV recovered from VF was generated using MEGA
4.1 with the neighbor-joining method with p distance and 1000 bootstrap
replicates. Significant bootstrap values are shown. Bar info is 0.05
nucleotide change. HsTTVx, human torque teno virus genotype x; PtTTVx,
Pan troglodytes torque teno virus genotype x; MfTTVx; Macaca fuscata
torque teno virus genotype x; HsTTMDVx, human torque teno midi virus
genotype x; HsTTMVx, human torque teno mini virus genotype
x. Sequences of TTV variants in VF-derived samples from individual
SHAPU patients, arbitrarily noted as, eg, SHAPU 4, or, in the case of
multiple TTV variants, eg, SHAPU 3.1–3.5, are shown.
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ocular disease SHAPU. Using sequence-independent amplifi-
cation of nucleic acids and sequencing, the presence of anello-
viruses in VF samples from patients with SHAPU was
demonstrated. This finding was corroborated by nested PCR
assays showing a significantly higher prevalence of the human
anelloviruses TTV, TTMDV, and TTMV in eyes of SHAPU
patients compared with disease controls. Since the discovery
of TTV and related anelloviruses approximately 15 years ago,
many investigations have been carried out to unravel their epi-
demiological, clinical, and pathogenic properties. Anellovirus
has been associated with several diseases, including multiple
sclerosis, rheumatic diseases, cancer, systemic lupus erythema-
tosis, non-A–E hepatitis, and asthma [30–37]. Herein, we
present data showing the presence of anelloviruses in VF of
patients with ocular diseases, indicating a novel association
between these viruses and uveitis, particularly in SHAPU
patients.
Analyses of the clinical parameters and patient character-
istics available for review revealed 2 major differences between
SHAPU and non-SHAPU patients. SHAPU patients were
usually children <10 years of age who underwent a therapeutic
vitrectomy commonly within the first week of disease, the
treatment of choice to preserve visual acuity in SHAPU
patients [1, 2]. Non-SHAPU patients, however, were all adults
and were first treated symptomatically using antibiotics, anti-
virals, and/or corticosteroids. Therapeutic vitrectomy was
applied as a second treatment option, usually multiple weeks
after onset of disease (data not shown). In herpesvirus- and
T. gondii–induced infectious uveitis, the intraocular viral and
parasitic load is inversely correlated with duration of disease,
mainly owing to effectiveness of the local immune response
evoked upon intraocular infection [2, 38–42]. Because signifi-
cant differences in intraocular viral loads in TTV PCR-positive
SHAPU and non-SHAPU VF samples were not observed, it is
unlikely that disease duration influences the detection of anel-
lovirus. The high incidence of SHAPU in young children con-
trasts with the increased risk of uveitis with increasing age
[43–45]. Children may be more prone to ocular infection
with anelloviruses than are adults, as was previously described
for other viral diseases such as the 2009 pandemic H1N1
influenza A virus [46].
The absence of anelloviruses in VF samples of retinal
detachment patients suggests an association between ocular
inflammation and ocular anellovirus infection. Ocular inflam-
mation causes perturbation of the blood-ocular barrier,
specifically barrier permeability, in many models of retinal
disease [29]. Because anellovirus infections cause a chronic
plasma viremia in most infected individuals [23], detection of
anelloviruses in VF samples may be the result of passive entry
of blood-derived anelloviruses into the vitreous cavity due to
breakdown of the blood-retina barrier in uveitis patients.
Indeed, most of the SHAPU and non-SHAPU patients with
anellovirus-positive VF also had TTV, TTMDV, and/or
TTMV viremia. Moreover, the median TTV load in VF was
relatively low compared with that previously described in
serum of viremic individuals [23]. These observations, in con-
junction with the phylogenetic analysis of TTV in the paired
serum and VF samples, suggest that the anelloviruses in VF
samples of both SHAPU and non-SHAPU patients have most
likely originated from the systemic TTV pool upon inflam-
mation-induced disruption of the blood-ocular barrier.
However, exogenous sources of the anelloviruses in VF cannot
be ruled out. For example, the VF sample of SHAPU patient
SV-2 was TTMDV PCR positive in the absence of a detectable
TTMDV viremia (Table 1).
In both scenarios, the epidemiological association between
epidemics of SHAPU and the seasonal presence of white
moths may be a key factor to explain the higher prevalence of
anelloviruses in SHAPU patients. Ocular-penetrating caterpil-
lar and tarantula hairs have been shown to induce severe
ocular inflammation [47, 48]. Notably, SHAPU patients docu-
ment close contact with white moths [1, 2, 4], and moth hairs
have incidentally been detected in corneas or even in the
anterior chamber of SHAPU patients (A. Manandhar, unpub-
lished observation). Cornea-penetrating moth hairs could
cause intraocular inflammation, allowing passive entry of
anelloviruses into the vitreous cavity from the bloodstream.
Alternatively, the ocular-penetrating hairs may be contami-
nated with anelloviruses, resulting in direct inoculation of
the virus into the eye. This scenario, although less likely, is
plausible because anelloviruses have also been detected in
river water, sewage, and polluted superficial waters worldwide
[49, 50].
In conclusion, the data presented demonstrate a high preva-
lence of TTV, TTMDV, and TTMV in VF samples of SHAPU
patients. The novel anellovirus disease association reported
here does not prove that these viruses are causally involved
in the pathogenesis of uveitis and SHAPU in particular, but
it cannot be excluded. Ultimately, experimental infection
studies in appropriate animal models are required to deter-
mine the pathogenic role of anelloviruses in the development
of uveitis.
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